Hydofon 50 mg/ ml Nórsko - nórčina - Statens legemiddelverk

hydofon 50 mg/ ml

2care4 generics aps - hydromorfonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 50 mg/ ml

Clotaxip 150 mikrog/ ml Nórsko - nórčina - Statens legemiddelverk

clotaxip 150 mikrog/ ml

2care4 generics aps - klonidinhydroklorid - injeksjonsvæske, oppløsning - 150 mikrog/ ml

Gammanorm 165 mg/ ml Nórsko - nórčina - Statens legemiddelverk

gammanorm 165 mg/ ml

octapharma ab - immunglobulin, normalt, humant - injeksjonsvæske, oppløsning - 165 mg/ ml

Octagam 50 mg/ ml Nórsko - nórčina - Statens legemiddelverk

octagam 50 mg/ ml

octapharma (2) - immunglobulin, normalt (humant) - infusjonsvæske, oppløsning - 50 mg/ ml

DuoTrav 40 mikrog/ ml / 5 mg/ ml Nórsko - nórčina - Statens legemiddelverk

duotrav 40 mikrog/ ml / 5 mg/ ml

2care4 aps - travoprost / timololmaleat - Øyedråper, oppløsning - 40 mikrog/ ml / 5 mg/ ml

Delipam 5 mg Nórsko - nórčina - Statens legemiddelverk

delipam 5 mg

2care4 generics aps - oksazepam - tablett - 5 mg

Delipam 10 mg Nórsko - nórčina - Statens legemiddelverk

delipam 10 mg

2care4 generics aps - oksazepam - tablett - 10 mg

Delipam 15 mg Nórsko - nórčina - Statens legemiddelverk

delipam 15 mg

2care4 generics aps - oksazepam - tablett - 15 mg

Flebogamma DIF (previously Flebogammadif) Európska únia - nórčina - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - humant normalt immunglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immune sera og immunglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Hizentra Európska únia - nórčina - EMA (European Medicines Agency)

hizentra

csl behring gmbh - human normal immunoglobulin (scig) - immunologiske mangelsyndrom - immune sera og immunglobuliner, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.